Dow Up0.11% Nasdaq Up0.50%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.48 0.01(0.29%) Aug 29, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 1,084   69   -  
Cost of Revenue -   -   -  
Gross Profit 1,084   69   -  
Operating Expenses
Research Development11,277  6,592  9,206  
Selling General and Administrative7,781  8,580  6,542  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (17,974) (15,103) (15,748)
Income from Continuing Operations
Total Other Income/Expenses Net6,094  (4)580  
Earnings Before Interest And Taxes(11,880)(15,107)(15,168)
Interest Expense -   -   -  
Income Before Tax(11,880)(15,107)(15,168)
Income Tax Expense(1,670)(1,351)(565)
Minority Interest -   -   -  
Net Income From Continuing Ops(10,210)(13,756)(14,603)
Non-recurring Events
Discontinued Operations57  570  (640)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (10,153) (13,186) (15,243)
Preferred Stock And Other Adjustments(9,325)(728)(728)
Net Income Applicable To Common Shares (19,478) (13,914) (15,971)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.